JAK2 and acute myeloid leukemia: Although some treatments used in the past, such as chlorambucil, 32P, and pipobroman, were shown to increase the rate of leukemic transformation, no compelling evidence supporting an association of therapy with AML has been produced for hydroxyurea, the mostly used drug, interferon, and anagrelide or JAK2 inhibitors more recently.